These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 23588735)

  • 21. Development of novel vaccine vectors: Chimpanzee adenoviral vectors.
    Guo J; Mondal M; Zhou D
    Hum Vaccin Immunother; 2018 Jul; 14(7):1679-1685. PubMed ID: 29300685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of Pre-Existing Neutralizing Antibody to Human Adenovirus Types 5 and 49 and Simian Type 23 in Chinese Population.
    Zou P; Wang Q; Zhang P; Luo S; Wang C; Zhang E; Zhang L; Li C; Li T
    Viral Immunol; 2023 Nov; 36(9):617-625. PubMed ID: 37903228
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of severe acute respiratory syndrome vaccine based on a nonhuman primate adenovirus in the presence of immunity against human adenovirus.
    Zhi Y; Figueredo J; Kobinger GP; Hagan H; Calcedo R; Miller JR; Gao G; Wilson JM
    Hum Gene Ther; 2006 May; 17(5):500-6. PubMed ID: 16716107
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Age dependence of adenovirus-specific neutralizing antibody titers in individuals from sub-Saharan Africa.
    Thorner AR; Vogels R; Kaspers J; Weverling GJ; Holterman L; Lemckert AA; Dilraj A; McNally LM; Jeena PM; Jepsen S; Abbink P; Nanda A; Swanson PE; Bates AT; O'Brien KL; Havenga MJ; Goudsmit J; Barouch DH
    J Clin Microbiol; 2006 Oct; 44(10):3781-3. PubMed ID: 17021110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chimpanzee adenovirus antibodies in humans, sub-Saharan Africa.
    Xiang Z; Li Y; Cun A; Yang W; Ellenberg S; Switzer WM; Kalish ML; Ertl HC
    Emerg Infect Dis; 2006 Oct; 12(10):1596-9. PubMed ID: 17176582
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A serological survey of human adenovirus serotype 2 and 5 circulating pediatric populations in Changchun, China, 2011.
    Yu B; Wang Z; Dong J; Wang C; Gu L; Sun C; Kong W; Yu X
    Virol J; 2012 Nov; 9():287. PubMed ID: 23176136
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of serum neutralizing antibodies to adenovirus type 5 (Ad5) and 41 (Ad41) in children is associated with age and sanitary conditions.
    Yang WX; Zou XH; Jiang SY; Lu NN; Han M; Zhao JH; Guo XJ; Zhao SC; Lu ZZ
    Vaccine; 2016 Nov; 34(46):5579-5586. PubMed ID: 27682509
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chimpanzee adenovirus vaccine protects against Zaire Ebola virus.
    Kobinger GP; Feldmann H; Zhi Y; Schumer G; Gao G; Feldmann F; Jones S; Wilson JM
    Virology; 2006 Mar; 346(2):394-401. PubMed ID: 16356525
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epitope mapping and characterization of a neutralizing monoclonal antibody against human adenovirus type 3.
    Tian X; Li C; Xue C; Li X; Zhou Z; Zhou R
    Virus Res; 2013 Nov; 177(2):189-93. PubMed ID: 24018287
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of preexisting immunity to adenovirus human serotype 5 antigens on the immune responses of nonhuman primates to vaccine regimens based on human- or chimpanzee-derived adenovirus vectors.
    McCoy K; Tatsis N; Korioth-Schmitz B; Lasaro MO; Hensley SE; Lin SW; Li Y; Giles-Davis W; Cun A; Zhou D; Xiang Z; Letvin NL; Ertl HC
    J Virol; 2007 Jun; 81(12):6594-604. PubMed ID: 17428852
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Seroprevalence of Neutralizing Antibodies against Six Human Adenovirus Types Indicates the Low Level of Herd Immunity in Young Children from Guangzhou, China.
    Tian X; Fan Y; Wang C; Liu Z; Liu W; Xu Y; Mo C; You A; Li X; Rong X; Zhou R
    Virol Sin; 2021 Jun; 36(3):373-381. PubMed ID: 33165772
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The sero-prevalence of anti-adenovirus 5 neutralizing antibodies is independent of a chronic hepatitis B carrier state in China.
    Huang D; Hennequi M; Elvachev A; Menguy T; Silvestre N; Yu D; Han Y; Inchauspé G; Zhang X; Zhu R
    Arch Virol; 2015 Apr; 160(4):1125-30. PubMed ID: 25616844
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mapping the epitope of neutralizing monoclonal antibodies against human adenovirus type 3.
    Tian X; Liu M; Su X; Jiang Z; Ma Q; Liao X; Li X; Zhou Z; Li C; Zhou R
    Virus Res; 2015 Oct; 208():66-72. PubMed ID: 26071383
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A recombinant trivalent vaccine candidate against human adenovirus types 3, 7, and 55.
    Liu T; Zhou Z; Tian X; Liu W; Xu D; Fan Y; Liao J; Gu S; Li X; Zhou R
    Vaccine; 2018 Apr; 36(16):2199-2206. PubMed ID: 29548605
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel replication-incompetent vector derived from adenovirus type 11 (Ad11) for vaccination and gene therapy: low seroprevalence and non-cross-reactivity with Ad5.
    Holterman L; Vogels R; van der Vlugt R; Sieuwerts M; Grimbergen J; Kaspers J; Geelen E; van der Helm E; Lemckert A; Gillissen G; Verhaagh S; Custers J; Zuijdgeest D; Berkhout B; Bakker M; Quax P; Goudsmit J; Havenga M
    J Virol; 2004 Dec; 78(23):13207-15. PubMed ID: 15542673
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of neutralizing antibodies against adenoviruses at Lucknow.
    Mathur A; Singh G; Singh UK; Mehrotra RM; Chaturvedi UC
    Indian J Med Res; 1978 Jan; 67():19-26. PubMed ID: 658993
    [No Abstract]   [Full Text] [Related]  

  • 37. The prevalence of neutralizing antibodies against AAV serotype 1 in healthy subjects in China: implications for gene therapy and vaccines using AAV1 vector.
    Liu Q; Huang W; Zhao C; Zhang L; Meng S; Gao D; Wang Y
    J Med Virol; 2013 Sep; 85(9):1550-6. PubMed ID: 23852678
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chimpanzee-origin adenovirus vectors as vaccine carriers.
    Tatsis N; Tesema L; Robinson ER; Giles-Davis W; McCoy K; Gao GP; Wilson JM; Ertl HC
    Gene Ther; 2006 Mar; 13(5):421-9. PubMed ID: 16319951
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complete nucleotide sequences and genome organization of four chimpanzee adenoviruses.
    Roy S; Gao G; Clawson DS; Vandenberghe LH; Farina SF; Wilson JM
    Virology; 2004 Jul; 324(2):361-72. PubMed ID: 15207622
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impaired humoral responses to subgenus D adenovirusenovirus infections in HIV-positive patients.
    Lord A; Bailey AS; Klapper PE; Snowden N; Khoo SH
    J Med Virol; 2000 Dec; 62(4):405-9. PubMed ID: 11074466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.